PMDA — authorised 10 September 2010
- Marketing authorisation holder: Daiichi Sankyo Company, Limited
- Status: approved
PMDA authorised Inavir on 10 September 2010
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 10 September 2010; PMDA has authorised it; PMDA has authorised it.
Daiichi Sankyo Company, Limited holds the Japanese marketing authorisation.